Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome to Develop Biomarkers for GSK Biologicals' Cancer Rx

NEW YORK (GenomeWeb News) – OncoMethylome Sciences said today it will develop DNA methylation biomarkers for GlaxoSmithKline Biologicals that the drugmaker will use in its cancer immunotherapy program. 
 
The Belgian company will test its portfolio of methylation markers on clinical samples from GSK Biologicals, said OncoMethylome’s CTO, Jim DiGuiseppi.
 
The company also said it is using a €2 million ($2.7 million) BioWin research grant it received earlier this year for cancer research to support the project.
 
Financial terms of the agreement were not released.
 

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.